Long Non-coding RNA CASC15 Promotes Melanoma Progression by Epigenetically Regulating PDCD4

Overview

Journal Cell Biosci

Publisher Biomed Central

Specialty Biology

Date 2018 Jul 18

PMID 30013768

Citations 32

Authors

Yakun Yin

Bin Zhao

Dongqin Li

Guangwen Yin

Affiliations

Soon will be listed here.

Abstract

Background: Long non-coding RNAs (LncRNAs) have been identified as critical regulators in a variety of cancer types. Cancer susceptibility candidate 15 (CASC15), a lncRNA located at chromosome 6p22.3, has been discovered to participate in melanoma progression and phenotype switching. Nevertheless, the roles and molecular mechanisms of CASC15 in melanoma are far from being understood.

Results: We found that CASC15 expression was up-regulated in melanoma tissues and associated with advanced pathological stages. Function experiments displayed that CASC15 knockdown hindered proliferation, facilitated apoptosis and suppressed invasion, while CASC15 overexpression facilitated proliferation and invasion in melanoma cells. Further mechanistic analysis showed that CASC15 epigenetically silenced the expression of programmed cell death 4 (PDCD4) by recruiting EZH2 and increasing H3K27me3 level at the promoter region of PDCD4. Additionally, PDCD4 overexpression inhibited proliferation, enhanced apoptosis and decreased invasion of melanoma cells. Moreover, CASC15-knockdown-induced anti-cancer effects were abated by PDCD4 down-regulation. Furthermore, depletion of CASC15 blocked tumor growth of melanoma by up-regulating PDCD4 in vivo.

Conclusions: CASC15 acts as an oncogene by negatively regulating PDCD4 expression via recruiting EZH2 and subsequently increasing H3K27me3 level. Together, our study indicates that CASC15/EZH2/PDCD4 may serve as a promising therapeutic target for melanoma intervention.

Citing Articles

Unravelling the Regulatory Roles of lncRNAs in Melanoma: From Mechanistic Insights to Target Selection.

Moras B, Sissi C Int J Mol Sci. 2025; 26(5).

PMID: 40076754 PMC: 11900516. DOI: 10.3390/ijms26052126.

YY1-induced lncRNA00511 promotes melanoma progression via the miR-150-5p/ADAM19 axis.

Chen Y, Fu X, Guo H, Fu X, Shi K, Gao T Am J Cancer Res. 2024; 14(2):809-831.

PMID: 38455406 PMC: 10915319.

Identification of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma by bioinformatics and experimental validation.

Xin T, Sun Y, Meng H, Zhang N, Peng B, Yang X Ann Med. 2023; 55(2):2251500.

PMID: 37643369 PMC: 10467521. DOI: 10.1080/07853890.2023.2251500.

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma.

Wozniak M, Czyz M Front Mol Biosci. 2023; 10:1170026.

PMID: 37325482 PMC: 10265524. DOI: 10.3389/fmolb.2023.1170026.

Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies.

Xiao Y, Xia Y, Wang Y, Xue C Genes Dis. 2023; 10(1):113-125.

PMID: 37013035 PMC: 10066279. DOI: 10.1016/j.gendis.2021.08.007.

References

Glusman G, Qin S, El-Gewely M, Siegel A, Roach J, Hood L . A third approach to gene prediction suggests thousands of additional human transcribed regions. PLoS Comput Biol. 2006; 2(3):e18. PMC: 1391917. DOI: 10.1371/journal.pcbi.0020018. View

Camacho C, Choudhari R, Gadad S . Long noncoding RNAs and cancer, an overview. Steroids. 2018; 133:93-95. DOI: 10.1016/j.steroids.2017.12.012. View

Ni N, Song H, Wang X, Xu X, Jiang Y, Sun J . Up-regulation of long noncoding RNA FALEC predicts poor prognosis and promotes melanoma cell proliferation through epigenetically silencing p21. Biomed Pharmacother. 2017; 96:1371-1379. DOI: 10.1016/j.biopha.2017.11.060. View

Wu Q, Xiang S, Ma J, Hui P, Wang T, Meng W . Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1. Mol Oncol. 2018; 12(6):799-813. PMC: 5983148. DOI: 10.1002/1878-0261.12187. View

Fernando T, Contreras J, Zampini M, Rodriguez-Malave N, Alberti M, Anguiano J . The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia. Mol Cancer. 2017; 16(1):126. PMC: 5517805. DOI: 10.1186/s12943-017-0692-x. View

Chen Y, Bian Y, Zhao S, Kong F, Li X . Suppression of PDCD4 mediated by the long non-coding RNA HOTAIR inhibits the proliferation and invasion of glioma cells. Oncol Lett. 2017; 12(6):5170-5176. PMC: 5228409. DOI: 10.3892/ol.2016.5323. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

Wan J, Yang J, Huang Y, Deng L . MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4. Oncol Lett. 2018; 15(2):1475-1482. PMC: 5776942. DOI: 10.3892/ol.2017.7445. View

Russell M, Penikis A, Oldridge D, Alvarez-Dominguez J, McDaniel L, Diamond M . CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res. 2015; 75(15):3155-66. PMC: 4526355. DOI: 10.1158/0008-5472.CAN-14-3613. View

10.

Tang Y, Cheung B, Atmadibrata B, Marshall G, Dinger M, Liu P . The regulatory role of long noncoding RNAs in cancer. Cancer Lett. 2017; 391:12-19. DOI: 10.1016/j.canlet.2017.01.010. View

11.

Rozeman E, Dekker T, Haanen J, Blank C . Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives. Am J Clin Dermatol. 2017; 19(3):303-317. DOI: 10.1007/s40257-017-0325-6. View

12.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

13.

Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X . Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Mol Cancer. 2017; 16(1):150. PMC: 5577767. DOI: 10.1186/s12943-017-0715-7. View

14.

Benetatos L, Voulgaris E, Vartholomatos G, Hatzimichael E . Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome. Int J Cancer. 2012; 133(2):267-74. DOI: 10.1002/ijc.27859. View

15.

He T, Zhang L, Kong Y, Huang Y, Zhang Y, Zhou D . Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis. Int J Oncol. 2017; 51(6):1722-1730. PMC: 5673007. DOI: 10.3892/ijo.2017.4175. View

16.

Yao X, Tang J, Zhu H, Jing Y . High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer. Eur Rev Med Pharmacol Sci. 2017; 21(24):5661-5667. DOI: 10.26355/eurrev_201712_14010. View

17.

Sun W, Yang Y, Xu C, Guo J . Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. Cancer Genet. 2017; 216-217:105-110. DOI: 10.1016/j.cancergen.2017.06.003. View

18.

Liu J, Zhai R, Zhao J, Kong F, Wang J, Jiang W . Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer. Int J Oncol. 2018; 52(5):1633-1642. DOI: 10.3892/ijo.2018.4303. View

19.

Wang Q, Zhu J, Wang Y, Dai Y, Wang Y, Wang C . Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma. Oncogene. 2017; 36(45):6225-6234. PMC: 5680133. DOI: 10.1038/onc.2017.228. View

20.

Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P . Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002; 298(5595):1039-43. DOI: 10.1126/science.1076997. View